Cleeland C S, Ryan K M
Pain Research Group, University of Wisconsin-Madison 53705-4013.
Ann Acad Med Singap. 1994 Mar;23(2):129-38.
Poorly controlled cancer pain is a significant public health problem throughout the world. There are many barriers that lead to undertreatment of cancer pain. One important barrier is inadequate measurement and assessment of pain. To address this problem, the Pain Research Group of the WHO Collaborating Centre for Symptom Evaluation in Cancer Care has developed the Brief Pain Inventory (BPI), a pain assessment tool for use with cancer patients. The BPI measures both the intensity of pain (sensory dimension) and interference of pain in the patient's life (reactive dimension). It also queries the patient about pain relief, pain quality, and patient perception of the cause of pain. This paper describes the development of the Brief Pain Inventory and the various applications to which the BPI is suited. The BPI is a powerful tool and, having demonstrated both reliability and validity across cultures and languages, is being adopted in many countries for clinical pain assessment, epidemiological studies, and in studies of the effectiveness of pain treatment.
癌症疼痛控制不佳是一个全球性的重大公共卫生问题。存在许多导致癌症疼痛治疗不足的障碍。一个重要的障碍是对疼痛的测量和评估不足。为解决这一问题，世界卫生组织癌症护理症状评估合作中心疼痛研究小组开发了简明疼痛评估量表（BPI），这是一种用于癌症患者的疼痛评估工具。BPI既测量疼痛强度（感觉维度），也测量疼痛对患者生活的干扰（反应维度）。它还会询问患者有关疼痛缓解、疼痛性质以及患者对疼痛原因的看法。本文描述了简明疼痛评估量表的开发过程以及它适用的各种应用场景。BPI是一个强大的工具，已在不同文化和语言中证明了其可靠性和有效性，正在许多国家被用于临床疼痛评估、流行病学研究以及疼痛治疗效果研究。
